Liang Yu

Liang Yu

Auto-generated profile, based on publicly available information

Liang Yu

The Sixth Laboratory, National Vaccine and Serum Institute (NVSI), Beijing 101111, China

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 September 2024 in Science
Verified
Journal Article
Closed access
YLYu Liang
Yu Liang
SSShuai Shao
Shuai Shao
XLXin Yu Li
Xin Yu Li
ZZZi Xin Zhao
Zi Xin Zhao
NLNing Liu
Ning Liu
QLQi Ming Li
Qi Ming Li
The respiratory syncytial virus (RSV) fusion (F) glycoprotein is highly immunogenic in its prefusion (pre-F) conformation. However, the protein is unstable, and its conformation must be stabilized for it to function effectively as an immunogen in vaccines. We present a mutagenesis strategy to arrest the RSV F protein in its pre-F state by blocking localized changes in protein structure that accompany large-scale conformational rearrangements. We generated a series of mutants and screened them in vitro to assess their potential for forming a stable pre-F. In animals, the immunogenicity of a representative mutant F protein, with a conformation confirmed by cryo–electron microscopy, elicited levels of neutralizing antibodies and protection against RSV-induced lung damage that were comparable to those of DS-Cav1, a pre-F used in a licensed vaccine.

1 August 2012 in Experimental Parasitology
Verified
Journal Article
Closed access
FNFang Ni
Fang Ni
YWYinan Wang
Yinan Wang
JZJing Zhang
Jing Zhang
LYLiang Yu
Liang Yu
WFWenzhen Fang
Wenzhen Fang
DLDamin Luo
Damin Luo